Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
R.J. Barts, G. Maislin, A. Fishman, P. Alfred.
Vasodilator therapy for primary pulmonary hypertension in children.
Circulation, 99 (1999), pp. 1197-1208
[2.]
R. Ziesche, V. Petkov, K. Wittmann, J. Kopatschka, L. Stiebellehner, P. Schenk.
Treatment with epoprostenol reverts nitric oxide non-responsiveness in patients with primary pulmonary hypertension.
Heart, 83 (2000), pp. 406-409
[3.]
D. Langleben, R.J. Barst, D. Badesch, B.M. Groves, V.F. Tapson, S. Murali.
Continuous infusion of epoprostenol improves the net balance between pulmonary endothelin-1 clearance and release in primary pulmonary hypertension.
Circulation, 99 (1999), pp. 3266-3271
[4.]
S. Kesten, J. Dainauskas, V. McLaughlin, S. Rich.
Development of nonspecific interstitial pneumonitis associated with long-term treatment of primary pulmonary hypertension with prostaciclin.
Chest, 116 (1999), pp. 566-569
[5.]
M.M. Hoeper, M. Schwarze, S. Ehlerding, A. Adler-Schuermeyer, E. Spiekerkoetter, J. Niedermeyer.
Long-term treatment of primary pulmonary hypertension with aerosolized iloprost, a prostacyclin analogue.
N Engl J Med, 342 (2000), pp. 1866-1870
[6.]
R. Wensel, C.H. Opitz, R. Ewert, L. Bruch, X. Kleber.
Effects of iloprost inhalation on exercise capacity and ventilatory efficiency in patients with primary pulmonary hypertension.
Circulation, 101 (2000), pp. 2388-2392
[7.]
S. Macherndl, M. Kneussl, H. Baumgarten, B. Schneider, V. Petkov, P. Schenk.
Long-term treatment of pulmonary hypertension with aerosolized iloprost.
Eur Respir J, 17 (2001), pp. 8-13
[8.]
C.B. Huddleston, E. Mendeloff, G.B. Mallory.
Trasplante pulmonary pediátrico.
An Esp Pediatr, 54 (2001), pp. 359-370
Copyright © 2002. Asociación Española de Pediatría
